2nd Rare & Genetic Kidney Disease Drug Development Summit
04
Oct
-
06
Oct
2022
When
Boston
Massachusetts
USA
Where

Understand Disease Pathogenesis to Advance Genetic Targets & Technologies Identify Disease Specific Biomarkers of Progression & Therapeutic Efficacy Confidently Recruit Patients & Execute Innovative Clinical Trials in Orphan Disease Populations A new paradigm in genetic testing, opportunities to attain accelerated approval with surrogate endpoints,

Similar Events

You May Like

Event

Hanson Wade

0/5
(0)

Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.

04 - 06 Oct 2022
In-Person

Speakers and Delegates
Industry Experts and Thought Leaders

Associate Professor
President and CEO
Director, Global Medical Affairs
Executive Director (Biology)
Chief Medical Officer
VP Head of Global Clinical Development
Chief Medical Officer
Global Project Head, Clinical Development, Rare Diseases and Rare Blood Disorders
Vice President, Head Global Clinical Operations
Senior Medical Director, Developmemt
Head of Clinical Renal and Executive Group Director, Early CVRM
Vice President of Clinical and Translational Research

Sponsors and Exhibitors
Brand, Media and Promotional Partners

Natera

Natera is a global leader in providing DNA testing across multiple clinical areas including women's health, organ health, and oncology.

Chinook Therapeutics, Inc.

Chinook Therapeutics (Nasdaq: KDNY) is a clinical-stage biotechnology company developing precision medicines for kidney diseases.

MDI Biological Laboratory

The MDI Biological Laboratory, located in Bar Harbor, Maine, is an independent, non-profit biomedical research institution focused on increasing healthy lifespan by slowing the aging process and enhancing our natural ability to repair and regenerate

MediBeacon Inc.

MediBeacon is a medical technology company focused on advancing fluorescent tracer agents and transdermal detection technology to provide vital and actionable measurement of organ function.

NephCure Kidney International

NephCure Kidney International’s mission is to accelerate research for effective treatments for rare forms of Nephrotic Syndrome, and to provide education and support that will improve the lives of those affected by these protein-spilling kidney disea

Organizer

Get emails from us

Thank you
Oops! Something went wrong